Antibacterial Therapy in Adults with COVID-19

Since the emergence of the Coronavirus-19 infectious disease (COVID-19) pandemic, a rising number of reports have underlined the risk of increasing antimicrobial resistance due to antibiotic overuse in COVID-19 patients. In addition, many physicians and pharmacists involved in antimicrobial stewards...

Descripció completa

Guardat en:

Dades bibliogràfiques
Format:	Online
Idioma:	anglès
Publicat:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Matèries:	COVID-19 antimicrobial use multicentre point-prevalence study Influenza co-infection secondary infections aspergillosis ivermectin randomized-controlled trial prevention treatment SARS-CoV-2 antiviral antibiotic azithromycin remdesivir macrolides virus coronavirus immunolides antivirus pandemics procalcitonin SARS virus community-acquired infections emergency service hospital pneumonia viral community-acquired pneumonia Mid-regional Pro-adrenomedullin ARDS biomarker prognosis superinfection bacterial co-infection bacterial superinfection antibiotic stewardship AMR antibiotics cephalosporin secondary infection variant of concern interleukin-6 receptor antagonist early administration mortality rates thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine
Accés en línia:	ONIX_20230405_9783036568133_80
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Sigues el primer a deixar un comentari!

Antibacterial Therapy in Adults with COVID-19

Ítems similars